| Neurological Disease Mechanisms and Treatments | Lifetime | 8 | NL 2 | 99.89 |
| Dementia and Cognitive Impairment Research | Lifetime | 27 | NL 2 | 99.90 |
| Alzheimer's disease research and treatments | Lifetime | 45 | NL 2 | 99.86 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 47 | NL 3 | 99.46 |
| Functional Brain Connectivity Studies | Lifetime | 206 | NL 11 | 99.44 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 80 | NL 7 | 99.13 |
| Aging, Elder Care, and Social Issues | Lifetime | 185 | NL 5 | 95.67 |
| S100 Proteins and Annexins | Lifetime | 116 | NL 5 | 98.44 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 280 | NL 11 | 98.76 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 596 | NL 41 | 98.46 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 778 | NL 56 | 98.25 |
| Cerebrovascular and genetic disorders | Lifetime | 56 | NL 5 | 97.43 |
| Health, Environment, Cognitive Aging | Lifetime | 203 | NL 5 | 96.89 |
| Cognitive Functions and Memory | Lifetime | 439 | NL 17 | 86.03 |
| Clusterin in disease pathology | Lifetime | 548 | NL 15 | 59.83 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 13 | NL 3 | 99.90 |
| Alzheimer's disease research and treatments | 2021-2025 | 23 | NL 3 | 99.74 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 111 | NL 6 | 98.43 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 35 | NL 3 | 96.20 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 137 | NL 5 | 97.01 |
| Tryptophan and brain disorders | 2021-2025 | 108 | NL 6 | 96.97 |
| Health, Environment, Cognitive Aging | 2021-2025 | 55 | NL 2 | 96.54 |
| Functional Brain Connectivity Studies | 2021-2025 | 576 | NL 23 | 95.29 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 899 | NL 50 | 91.30 |
| Patient-Provider Communication in Healthcare | 2021-2025 | 258 | NL 29 | 87.99 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 201 | NL 2 | 85.58 |
| Cerebrovascular and genetic disorders | 2021-2025 | 76 | NL 15 | 83.20 |
| Cognitive Functions and Memory | 2021-2025 | 79 | NL 4 | 81.31 |
| Aging, Elder Care, and Social Issues | 2021-2025 | 285 | NL 8 | 73.91 |
| Folate and B Vitamins Research | 2021-2025 | 874 | NL 18 | 68.88 |
| Inflammation biomarkers and pathways | 2021-2025 | 420 | NL 11 | 41.52 |
